TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Nucleosides where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Nucleosides technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Nucleosides

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Nucleosides industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Nucleosides industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Nucleosides industry

Labelled NucleotidesILLUMINA CAMBRIDGENov 17, 2021LATVIA MGI TECH SIA
Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral PolymeraseSCHERINGJan 7, 2021GILEAD SCIENCES
Antisense DesignSANTARIS PHARMANov 12, 2020IONIS PHARMACEUTICALS
Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGEAug 24, 2020LATVIA MGI TECH SIA
Modified NucleotidesILLUMINA CAMBRIDGEAug 24, 2020LATVIA MGI TECH SIA
Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGEApr 29, 2020MGI TECH HONG KONG
Modified Fluorinated Nucleoside AnaloguesPHARMASSETDec 5, 2019GILLARD
Labelled NucleotidesILLUMINA CAMBRIDGEJun 26, 2019HOFFMANN EITLE
Chemical CompoundsNUCANADec 17, 2018GILEAD SCIENCES
Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGENov 28, 2018HOFFMANN EITLE

To stay ahead in the competitive Nucleosides industry, companies are constantly innovating. Here are the top patents facing oppositions in the Nucleosides industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCES3
Dec 25, 2019Labelled NucleotidesILLUMINA CAMBRIDGE2
Oct 7, 2020Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose TransporterMITSUBISHI TANABE PHARMA2
Feb 28, 2018Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGE2
Sep 26, 2018Labelled NucleotidesILLUMINA CAMBRIDGE1
Apr 8, 2020Modified Nucleotides For Polynucleotide SequencingILLUMINA CAMBRIDGE1
Feb 17, 2021Labelled NucleotidesILLUMINA CAMBRIDGE1
Mar 6, 2019Modified Fluorinated Nucleoside AnaloguesGILEAD PHARMASSET1
Apr 22, 2020Modified NucleotidesILLUMINA CAMBRIDGE1
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral PolymeraseMERCK SHARP & DOHME1